Fact-checked by Grok 2 weeks ago

Metabolic network

A metabolic network is the comprehensive system of interconnected biochemical reactions within a cell or organism that converts carbon and energy sources, along with electron donors and acceptors, into biomass, energy, and by-products essential for sustaining life. These networks encompass all enzymatic transformations of metabolites, forming a dynamic web that integrates physical processes, regulatory interactions, and physiological properties to maintain homeostasis. At its core, a metabolic network comprises metabolites as nodes—such as substrates, products, activators, and inhibitors—and directed edges representing chemical reactions catalyzed by , often organized into major pathways like , the tricarboxylic acid () cycle, and . These components enable the breakdown of nutrients () to generate energy in the form of ATP and the synthesis of complex molecules () for growth and repair, with fluxes regulated by environmental cues, genetic expression, and mechanisms. Disruptions in network balance, such as enzyme deficiencies or pathway imbalances, underlie metabolic disorders like and contribute to phenomena like the Warburg effect in cancer cells, where is upregulated even in oxygen-rich conditions. In , metabolic networks are modeled as graph structures exhibiting scale-free and small-world properties, where a few highly connected "" metabolites and enzymes link disparate pathways, conferring robustness and efficiency across from to s. Genome-scale reconstructions, such as the human Recon 2.2 model with 7,785 reactions and 1,675 genes or the iJO1366 with 2,583 reactions and 1,366 genes, enable predictive simulations using techniques like to forecast cellular behavior under varying conditions. These models have revolutionized applications in for production, target identification in precision medicine, and for designing novel . Evolutionarily, metabolic networks trace back over 3.5 billion years, with conserved core elements like the 146 protein families in the last bacterial common ancestor forming the foundational architecture that has adapted across domains of while retaining universal structural motifs for error tolerance and evolvability. Ongoing research leverages high-throughput omics data and computational frameworks to map network rewiring in response to stress or disease, bridging fundamental with therapeutic innovation.

Fundamentals

Definition

A metabolic network is a biochemical system represented as a , in which nodes correspond to metabolites—small organic molecules such as , sugars, , and —and directed edges represent enzymatic reactions that transform one or more metabolites into product metabolites. This graph-theoretic model captures the interconnected pathways of chemical conversions essential to cellular processes, with each edge denoting a specific biochemical reaction catalyzed by enzymes. Key characteristics of metabolic networks include their directed , reflecting the thermodynamic feasibility and directionality of reactions, where irreversible reactions form unidirectional edges and reversible ones allow bidirectional connections. Additionally, these networks are often weighted to account for , the quantitative coefficients in reaction equations that specify the molar ratios of reactants and products, enabling precise modeling of . Such structural features distinguish metabolic networks from undirected or unweighted graphs used in other contexts, emphasizing the flow of matter through stoichiometric constraints. Unlike signaling networks, which model propagation through protein interactions and post-translational modifications, or gene regulatory networks, which depict transcriptional control among and transcription factors, metabolic networks exclusively focus on the catabolic breakdown and anabolic synthesis of small molecules via enzymatic . This delineation underscores the unique role of metabolic networks in representing material transformations rather than regulatory signaling or genetic control mechanisms.

Biological Significance

Metabolic networks play a central role in cellular energy production by orchestrating pathways such as and , which generate (ATP) to fuel essential life processes. In , glucose is oxidized to pyruvate, yielding a net of two ATP molecules per glucose under conditions, providing rapid energy for cells in low-oxygen environments. , occurring in the mitochondria of eukaryotic cells, couples the with to produce the majority of cellular ATP, approximately 30-32 molecules per glucose, through proton gradient-driven . These interconnected pathways ensure efficient across diverse physiological states. Beyond energy generation, metabolic networks facilitate , enabling the production of essential biomolecules like through dedicated pathways integrated within the broader network. For instance, the and reactions synthesize aromatic and non-essential , linking carbon skeletons from central to for protein building blocks. This anabolic function supports growth, repair, and signaling, with disruptions leading to metabolic disorders. Metabolic networks maintain by adapting to environmental perturbations via intricate feedback loops, including of key . Allosteric effectors bind to sites distinct from the , modulating activity to balance levels; for example, in is inhibited by high ATP or citrate, preventing overproduction during energy surplus. Such network-wide regulation enhances robustness, allowing cells to respond dynamically to availability or while preserving steady-state conditions. The evolutionary conservation of metabolic networks underscores their fundamental importance, with core pathways like the tricarboxylic acid (TCA) cycle present in both prokaryotes and eukaryotes, albeit with increasing complexity in higher organisms. The TCA cycle, comprising eight enzymes that oxidize to generate reducing equivalents for ATP production, originated early in and remains highly preserved, reflecting selective pressure for efficient carbon . Variations, such as compartmentalization in eukaryotic mitochondria, have evolved to accommodate specialized functions without altering sequence.

Components and Structure

Metabolites and Reactions

Metabolites serve as the fundamental nodes in metabolic networks, representing small molecules that participate in biochemical transformations. They are broadly classified into , which are the initial compounds consumed in reactions; products, the end compounds generated; intermediates, transient species formed and further processed within pathways; and cofactors, non-protein molecules that assist enzymes in catalysis and may undergo transient structural changes but are regenerated, such as ATP (hydrolyzed to during energy transfer and regenerated) and NAD⁺ (reduced to NADH in reactions and reoxidized). Glucose exemplifies a central metabolite, acting as a primary in carbon and connecting multiple pathways like and the . Reactions form the directed edges connecting these metabolites, typically catalyzed by enzymes that lower activation energies and ensure specificity. defines the quantitative relationships between reactants and products in these reactions, maintaining mass and charge balance across the network. For instance, the overall of , a core catabolic pathway, is represented as: \text{glucose} + 2\,\text{NAD}^{+} + 2\,\text{ADP} \rightarrow 2\,\text{pyruvate} + 2\,\text{NADH} + 2\,\text{ATP} This equation highlights the conversion of one glucose molecule into two pyruvates, coupled with net energy gain in the form of ATP and reducing equivalents. Metabolic reactions are categorized into types such as transport reactions, which move across membranes without chemical alteration, and conversion reactions, which transform one into another through rearrangements or group transfers. Compartmentalization organizes metabolites and reactions within cellular organelles, enhancing and by isolating incompatible processes. In eukaryotic cells, for example, oxidative is confined to mitochondria, where metabolites like pyruvate are imported for Krebs cycle and activities, preventing interference with cytosolic . This spatial segregation also facilitates cofactor recycling, such as NAD⁺/NADH shuttling across mitochondrial membranes.

Network Topology

Metabolic networks are typically represented as directed graphs, with metabolites serving as nodes and biochemical reactions as edges connecting substrates to products. These networks display a , where the distribution of nodes follows a power-law, meaning a few highly connected hubs dominate while most nodes have low connectivity. Prominent hubs include central metabolites like pyruvate, which participate in numerous reactions across pathways such as , the tricarboxylic acid cycle, and , underscoring their pivotal role in network connectivity. A defining feature of metabolic network topology is its inherent modularity, organized into semi-independent functional modules corresponding to biochemical pathways, such as the glycolysis module that processes glucose to pyruvate. This modularity is hierarchical, with sub-modules nested within larger pathway clusters, enabling efficient information flow and functional specialization while integrating global connectivity. Scale-free properties and modularity coexist, as hubs often bridge modules, facilitating cross-pathway interactions. Key topological metrics reveal small-world characteristics in metabolic networks, including a high —indicating dense local connections within modules—and a low , typically around 2-4 in bacterial networks, which supports rapid propagation across the system. These properties contribute to robustness against perturbations, such as knockouts, where random removal of nodes minimally disrupts overall connectivity due to the scale-free design and redundant pathways. A notable enhancing this is the bow-tie architecture observed in metabolism, featuring a narrow "knot" of core intermediates flanked by broad input ( uptake) and output ( production) layers, allowing the network to maintain function under varying conditions. Comparative analyses highlight topological distinctions between prokaryotic and eukaryotic metabolic networks. Prokaryotic networks, exemplified by bacteria like E. coli, are compact and unified within a single cytoplasmic compartment, resulting in shorter path lengths and higher interconnectivity among reactions. In contrast, eukaryotic networks are expanded and more fragmented due to subcellular compartmentalization into organelles such as mitochondria and peroxisomes, necessitating additional transport edges across membranes and increasing overall network diameter while amplifying modularity for specialized functions.

Reconstruction Methods

Genome-Scale Modeling

Genome-scale modeling refers to the process of constructing detailed computational representations of an organism's entire metabolic network, encompassing thousands of reactions derived primarily from genomic data. These models serve as structured bases that link genes to enzymes and biochemical transformations, enabling the of metabolic behaviors at a systems level. The approach originated from efforts to map comprehensively, evolving into a standardized methodology for diverse organisms. The reconstruction pipeline begins with an annotated , where open reading frames are identified and associated with enzymatic functions using like or BioCyc to infer potential reactions. This initial draft model, often automated, is then manually curated to ensure biochemical accuracy, including the addition of transport reactions and compartmentalization based on known cellular localization. Gap-filling addresses inconsistencies, such as missing reactions required for production, by hypothesizing and validating alternative pathways through or experimental data. This multi-step process typically involves iterative refinement to achieve a high-quality, predictive model. Key tools and frameworks facilitate this workflow, with the Constraint-Based Reconstruction and Analysis (COBRA) Toolbox being a cornerstone for building, curating, and validating genome-scale models in or environments. For instance, the iJR904 model for K-12, comprising 904 genes and 931 reactions, exemplifies early automated reconstruction followed by manual verification to predict metabolic fluxes accurately. Similarly, the human Recon3D model integrates 13,543 reactions, highlighting the scalability of these tools for complex eukaryotes. More recent efforts include the Human1 model (2020), unifying Recon and HMR series, and continued updates via community resources like the Metabolic Atlas as of 2025. Challenges in genome-scale modeling include handling incomplete genomic annotations, which can lead to gaps in pathway coverage, necessitating extensive literature mining for resolution. Organism-specific variations, such as tissue-specific isoforms in humans or differences in microbes, further complicate curation, often requiring community-driven updates to maintain model relevance and accuracy.

Data Integration Techniques

techniques play a crucial role in refining and validating metabolic network models by incorporating diverse biological datasets beyond initial genome-based reconstructions. These methods enhance model accuracy by constraining reaction fluxes and metabolite concentrations to align with experimental observations, thereby bridging the gap between static network structures and dynamic cellular behaviors. data, in particular, provide quantitative insights into system states under specific conditions, allowing for context-specific adjustments to genome-scale metabolic models (GEMs). Incorporation of omics data involves mapping high-throughput measurements to network components. Metabolomics data, which quantify intracellular and extracellular concentrations, can be used to set bounds on rates or identify active pathways by correlating levels with flux predictions. Transcriptomics data, capturing levels, inform availability by adjusting upper limits proportional to mRNA abundances, assuming a between transcription and catalytic capacity. data offer direct measures of protein levels, enabling more precise flux constraints through integration with kinetic parameters or stoichiometric models; for instance, methods like large-scale Bayesian (LBFBA) incorporate proteomic abundances to refine flux distributions in models. These integrations often employ algorithms such as learning-based or constraint-based optimization to reconcile multi-omics inputs, improving for phenotypic outcomes. Validation of integrated models relies on experimental benchmarks to ensure physiological relevance. Comparison with measured fluxes from 13C-labeling experiments, such as 13C-metabolic flux analysis (13C-MFA), tests model predictions against isotopomer distributions in key metabolites, quantifying intracellular fluxes with high resolution in microbial and mammalian systems; goodness-of-fit metrics, like chi-squared tests, confirm model fidelity when simulated labeling patterns match observed data. Thermodynamic constraints further validate spontaneity by enforcing negative changes (ΔG < 0) for irreversible reactions, using group contribution methods to estimate ΔG from metabolite concentrations and standard potentials, thus eliminating infeasible flux solutions in GEMs. These approaches collectively reduce solution spaces and enhance model robustness. Databases like KEGG, BioCyc, and MetaCyc serve as foundational resources for data integration by supplying curated reaction rules, pathway architectures, and stoichiometric coefficients. KEGG provides pathway maps and enzyme annotations that facilitate automated gap-filling in network reconstructions, integrating genomic and metabolomic data through its orthology-based mappings. BioCyc, encompassing organism-specific databases, offers detailed metabolic networks with evidence-linked reactions, enabling the import of omics data for flux prediction and validation via tools like the Metabolic Network Explorer. MetaCyc, as a non-redundant reference of experimentally verified pathways, supports de novo pathway prediction and integration by providing reaction directionality and thermodynamic data, aiding in the refinement of GEMs across diverse taxa. These resources ensure standardized, evidence-based inputs for multi-omics reconciliation.

Analysis Approaches

Flux Balance Analysis

Flux balance analysis (FBA) is a constraint-based computational method used to predict steady-state metabolic fluxes in genome-scale metabolic networks by solving a linear programming problem. It assumes that the metabolic system operates at quasi-steady state, where the concentrations of intracellular metabolites remain constant over time, leading to a balance of fluxes into and out of each metabolite. This approach relies on the stoichiometric matrix S, which represents the network's reactions and metabolites as derived from genome-scale reconstructions. The core of FBA involves optimizing an objective function, typically microbial growth rate or biomass production, subject to mass balance constraints and thermodynamic bounds on reaction fluxes. Mathematically, this is formulated as maximizing Z = c^T v, where v is the flux vector of dimension n (number of reactions), and c is a coefficient vector specifying the objective (e.g., c with 1 for the biomass reaction and 0 elsewhere). The primary constraint is the steady-state condition S v = 0, where S is the m \times n stoichiometric matrix (m metabolites). Additional constraints include lower and upper bounds on fluxes, lb \leq v \leq ub, often set to reflect reversibility, enzyme capacities, or experimental data (e.g., lb_i = 0 for irreversible reactions). The flux vector v quantifies the rates of metabolite transformation through the network, providing predictions of intracellular flows without requiring kinetic parameters. This formulation was first applied to quantitatively predict growth and by-product secretion in Escherichia coli. A key variant, parsimonious FBA (pFBA), extends standard FBA by incorporating a secondary objective to minimize total enzyme usage after maximizing the primary objective, assuming cellular economy in resource allocation. In pFBA, the optimization first maximizes growth \max c^T v subject to S v = 0 and bounds, then minimizes \min \sum |v_j| (or a weighted sum) over the optimal growth solutions, yielding a unique flux distribution closer to experimental observations. This hierarchical approach has been shown to align better with proteomic data in evolved E. coli strains. FBA is widely used for predicting the effects of genetic perturbations, such as gene knockouts, by setting the flux of associated reactions to zero and re-solving the optimization to assess impacts on the objective function. For instance, reactions whose knockout reduces growth to zero are deemed essential, enabling in silico essentiality analysis that matches experimental gene deletion phenotypes in E. coli with high accuracy. This capability has facilitated the identification of metabolic vulnerabilities across organisms. Recent advances (as of 2025) include hybrid approaches like NEXT-FBA, which integrate data-driven elements to enhance prediction accuracy with minimal input data requirements, and couplings of FBA with reactive transport modeling for simulating microbial metabolism in environmental contexts.

Dynamic Modeling

Dynamic modeling of metabolic networks employs kinetic approaches to capture the time-dependent evolution of metabolite concentrations and reaction fluxes, enabling simulations of how networks respond to perturbations such as changes in nutrient availability or enzyme activity. These models typically formulate the system using ordinary differential equations (ODEs) that describe the rate of change in metabolite concentrations as the net result of production and consumption rates across reactions. For a metabolite M_i, the governing equation is \frac{d[M_i]}{dt} = \sum v_{j \rightarrow i} - \sum v_{k \rightarrow i}, where v represents the reaction rates, aggregated over forward and reverse directions. Reaction rates are often derived from enzyme kinetics, with the Michaelis-Menten equation providing a foundational form: v = \frac{V_{\max} [S]}{K_m + [S]}, where V_{\max} is the maximum rate, [S] is substrate concentration, and K_m is the Michaelis constant. This framework allows for the prediction of transient behaviors, contrasting with steady-state methods by incorporating temporal dynamics and regulatory mechanisms like allosteric inhibition. Hybrid methods integrate kinetic ODEs with constraint-based approaches, such as flux balance analysis (FBA), to bridge multi-scale analyses where detailed kinetics are applied to subsystems while leveraging steady-state flux constraints for genome-scale coverage. In these hybrids, ODEs model dynamic compartments (e.g., signaling pathways), while FBA optimizes fluxes in larger metabolic networks, facilitating simulations of coupled processes like gene regulation and metabolism. A key challenge in developing such models is parameter estimation, which requires fitting kinetic constants (e.g., V_{\max}, K_m) to experimental time-course data; however, incomplete, noisy measurements often lead to identifiability issues and high computational demands for optimization. Techniques like ensemble modeling address this by generating parameter sets that fit data within statistical bounds, improving robustness. Applications of dynamic modeling include integrative simulations of insulin signaling and metabolic networks in diabetes, where ODE-based models capture how insulin receptor activation propagates through phosphorylation cascades to modulate glucose uptake and glycolysis. For instance, Sedaghat et al. developed an ODE model linking insulin binding to GLUT4 translocation and glycogen synthesis, revealing feedback loops that amplify insulin sensitivity. More recent extensions, such as those by Noguchi et al., incorporate metabolic fluxes to simulate insulin resistance states, predicting altered dynamics in hepatic gluconeogenesis under diabetic conditions. These models aid in understanding disease progression and testing therapeutic interventions by forecasting concentration trajectories over time. As of 2025, emerging developments include neural-mechanistic hybrid models that combine machine learning with ODE frameworks to improve phenotype predictions in metabolic networks, and integrations of multimodal large language models with mechanistic simulations for advanced glucose homeostasis modeling in diabetes.

Applications

Biotechnology and Engineering

Metabolic engineering leverages reconstructed metabolic networks to optimize microbial pathways for industrial production, enabling the redirection of carbon fluxes toward high-value biofuels and pharmaceuticals. In biofuel production, has been extensively engineered to enhance ethanol yields from lignocellulosic feedstocks. For instance, strategies involving the overexpression of xylose transporters and isomerases, combined with evolutionary adaptation, have increased ethanol titers to over 50 g/L in engineered strains, surpassing wild-type capabilities on pentose sugars. Similarly, pathway optimization in for artemisinin precursors, such as amorphadiene, has achieved production levels up to 25 g/L through mevalonate pathway engineering and cytochrome P450 integration, providing a scalable alternative to plant extraction for antimalarial drugs. Synthetic biology tools, particularly CRISPR-based genome editing, facilitate precise rerouting of metabolic fluxes by targeting key regulatory nodes in central carbon metabolism. For example, CRISPR-Cpf1 has been used to edit for succinate production from softwood hydrolysates, achieving titers of 39.67 g/L in fed-batch fermentation with a yield of 0.77 g succinate per g sugars consumed by deleting lactate dehydrogenase and overexpressing succinate export genes, reducing byproducts. These edits often integrate with flux balance analysis (FBA) to predict and validate flux redistributions, ensuring efficient resource allocation in industrial fermentations. Such approaches exemplify how synthetic designs can transform microbial chassis into tunable factories for organic acids used in bioplastics and chemicals. Recent advances as of 2024 include multi-omics integration in genome-scale models for engineering microbial consortia in biofuel production from lignocellulose, enhancing yields through host-microbe metabolic interactions. Case studies in industrial amino acid production highlight the impact of FBA-guided knockouts in Corynebacterium glutamicum, a cornerstone organism for L-lysine and L-glutamate manufacturing. Metabolic engineering strategies, including deletions to redirect flux in the aspartate pathway, have boosted L-lysine productivity to around 150 g/L with yields of approximately 0.5 g/g glucose in fed-batch processes. These optimizations, informed by genome-scale models, have scaled global production to millions of tons annually, demonstrating the translational power of metabolic network engineering from computational prediction to commercial bioreactors.

Biomedical Research

Metabolic network modeling has been instrumental in elucidating disease-specific alterations, particularly in cancer where the Warburg effect drives upregulated glycolysis even under aerobic conditions. This phenomenon, characterized by increased and lactate production, supports rapid proliferation and biosynthetic demands in tumor cells. Using flux balance analysis (FBA) within computational models, researchers have shown that a 20- to 40-fold increase in glycolytic flux (parameterized as p_G > 20) correlates with maximal tumor aggressiveness, enhanced acidity for immune evasion, and competitive glucose consumption in hypoxic microenvironments. In metabolic disorders like , FBA applied to genome-scale networks reveals flux imbalances, such as reduced and altered lipid oxidation in insulin-resistant states, as simulated in pancreatic and models. These imbalances highlight disrupted pathways in fed versus conditions, aiding in identification for disease progression. Therapeutic applications leverage metabolic networks for drug target identification through simulated perturbations, exemplified by statins that inhibit 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) in the biosynthesis pathway. Genome-scale reconstructions like Recon 1 integrate this enzyme into a coupled reaction network, predicting how statin inhibition reduces mevalonate production and downstream isoprenoid synthesis, thereby lowering cardiovascular risk while revealing potential side effects like . Pharmacometabolomics further advances by analyzing baseline metabolite profiles to forecast individual responses to s, linking variations in pathways like and to efficacy and toxicity. For instance, pre-dose signatures in and networks have predicted outcomes for therapies like acetaminophen, enabling tailored dosing to minimize adverse events. Human metabolic models, such as the Recon series, enable prediction of off-target drug effects by simulating knockouts or inhibitions within the network. In a renal context-specific Recon 1 model with 1,587 reactions, structural analysis via the algorithm identified off-targets for drugs like torcetrapib, such as PTGIS inhibition leading to prostaglandin imbalances and , validated against clinical data with high predictive accuracy (ROC analysis). Recent 2020s studies on have applied similar network approaches to uncover viral-induced rewiring, where reduces oxidative flux into the cycle while boosting activity, enhancing signaling for replication. This metabolic shift, observed in infected cell lines and airway cultures, suggests vulnerabilities targetable by inhibitors like rapamycin, reducing viral loads without broad . As of 2025, extensions of these models have been used to simulate metabolic changes in , identifying persistent flux alterations in energy metabolism for potential therapeutic targets.

References

  1. [1]
    Metabolic Network - an overview | ScienceDirect Topics
    A metabolic network is an organismal system that converts carbon and energy sources and electron donors and acceptors into biomass, energy, and by-products.
  2. [2]
    Metabolic Network - an overview | ScienceDirect Topics
    The metabolic network of a cell or an organism is its complete set of metabolic reactions. The complete metabolic networks of several organisms, from bacteria ...
  3. [3]
    Metabolic Networks And Systems Biology - Nature
    Metabolic networks constitute the complex web of biochemical reactions that sustain cellular life, integrating enzymes, substrates, and regulatory elements.
  4. [4]
    [PDF] The large-scale organization of metabolic networks
    This may indi- cate that metabolic organization is not only identical for all living organisms, but also complies with the design principles of robust and error ...
  5. [5]
    The metabolic network of the last bacterial common ancestor - Nature
    Mar 26, 2021 · We identified 146 protein families that trace to the last bacterial common ancestor, LBCA, and form the conserved predicted core of its metabolic network.
  6. [6]
    Metabolic Connectome and Its Role in the Prediction, Diagnosis ...
    Jan 26, 2024 · Metabolic networks, which consist of complex systems comprising hundreds of metabolites and their interactions, play a critical role in biological research.
  7. [7]
    Current Understanding of the Formation and Adaptation of Metabolic ...
    Metabolism can be defined as a series of chemical reactions, and is often presented as a network or graph, which consists of a set of nodes and edges (called ...
  8. [8]
    Flux-dependent graphs for metabolic networks - Nature
    Aug 14, 2018 · Our graphs encode the directionality of metabolic flows via edges that represent the flow of metabolites from source to target reactions. The ...
  9. [9]
    Using the Topology of Metabolic Networks to Predict Viability of ...
    In this representation of the metabolic network, circular nodes represent metabolites, rectangular nodes represent reactions, and directed edges indicate their ...
  10. [10]
  11. [11]
    [PDF] Biological Networks - Brown CS
    Biological networks include gene regulatory, signal transduction, protein-protein interaction, metabolic networks, and phylogenetic trees, which are species- ...
  12. [12]
    Gene network requirements for regulation of metabolic ... - Nature
    Mar 11, 2013 · We show that metabolic network optimisation over a range of environments results in an input-output relationship for the gene network that guarantees optimal ...
  13. [13]
    Biochemistry, Glycolysis - StatPearls - NCBI Bookshelf - NIH
    Glycolysis is a metabolic pathway and anaerobic energy source that oxidizes glucose, producing 4 ATP, 2 NADH, and 2 pyruvates, and splits glucose into two ...
  14. [14]
    Oxidative phosphorylation: regulation and role in cellular and tissue ...
    Oxidative phosphorylation provides most of the ATP that higher animals and plants use to support life and is responsible for setting and maintaining metabolic ...
  15. [15]
    Amino acid metabolism in health and disease - Nature
    Sep 13, 2023 · Amino acid metabolism disorders have been linked with a number of pathological conditions, including metabolic diseases, cardiovascular diseases, immune ...
  16. [16]
    The stability and robustness of metabolic states - PubMed Central
    Since allosteric regulation occurs within metabolic networks as feedback or feed-forward loops, it operates network-wide and affects the dynamic properties ...
  17. [17]
    TCA cycle signalling and the evolution of eukaryotes - PubMed Central
    Oct 30, 2020 · The conservation of TCA cycle remodelling across organisms and in itaconate production suggests that itaconatemediated metabolic regulation ...
  18. [18]
    Evolution and Functional Implications of the Tricarboxylic Acid Cycle ...
    Abstract. The tricarboxylic acid (TCA) cycle, a crucial component of respiratory metabolism, is composed of a set of eight enzymes present in the mitochond.
  19. [19]
    Metabolic Pathway - an overview | ScienceDirect Topics
    Metabolic pathways are defined as a series of biochemical reactions that convert substrates into products, facilitating the transformation of matter and ...
  20. [20]
    Discovery of substrate cycles in large scale metabolic networks ...
    Feb 13, 2015 · Examples of cofactors include electron and phosphate group donors and receivers (e.g. NADH, NAD+, ATP, ADP, etc.) as well as inorganic molecules ...Methods · Metabolic Models And Graph... · Cofactors Involved In...
  21. [21]
    Glycolysis: A multifaceted metabolic pathway and signaling hub
    Glycolysis is a highly conserved metabolic pathway responsible for the anaerobic production of adenosine triphosphate (ATP) from the breakdown of glucose ...
  22. [22]
    Metabolic pathway compartmentalization: an underappreciated ...
    Metabolic pathways are spatially and temporally compartmentalized. · Metabolic pathway compartmentalization facilitates and is necessary for cellular functions.
  23. [23]
    Metabolic sensing and control in mitochondria - ScienceDirect.com
    Mar 16, 2023 · Central to metabolic compartmentalization is a highly regulated biochemical interface consisting of a selectively permeable mitochondrial inner ...
  24. [24]
    'load points' and 'choke points' in the metabolic networks
    A comparative study of metabolic pathways based on shortest path analysis reveals the metabolic network topology of B. ... pyruvate—a hub—has an incoming load ...
  25. [25]
    MANET 3.0: Hierarchy and modularity in evolving metabolic networks
    Oct 24, 2019 · The network structure shows an increase in hierarchical modularity and scale-free behavior as metabolic networks unfold in evolutionary time.
  26. [26]
    Evolutionary significance of metabolic network properties - Journals
    Nov 30, 2011 · The central findings in network-based research suggest that there exist simple mechanisms directing the evolution of both engineered and natural ...
  27. [27]
    Robustness Analysis of the Escherichia Coli Metabolic Network
    The results indicate that the E. coli metabolic network is robust with respect to the flux levels of these enzymes. The metabolic flux in the transketolase ...Missing: perturbations bow- tie architecture
  28. [28]
    Hierarchical modularity of nested bow-ties in metabolic networks
    Network decomposition of three microbes (Escherichia coli, Aeropyrum pernix and Saccharomyces cerevisiae) shows that almost all of the sub-networks exhibit a ...Missing: perturbations | Show results with:perturbations
  29. [29]
    Analysis of the differences in metabolic network expansion between ...
    By topological analysis, several models including preferential attachment and hierarchical modules have been proposed to explain how these networks are ...
  30. [30]
    Compartment and hub definitions tune metabolic networks for ...
    Jan 23, 2020 · Eukaryotic cells further compartmentalize groups of these reactions within membrane-bound organelles, using protein transporters to regulate ...
  31. [31]
    Integrating Omics Data in Genome-Scale Metabolic Modeling
    Jul 18, 2023 · The integration of omics data with GEMs has the potential to lead to new insights, and to advance our understanding of molecular mechanisms in human health and ...
  32. [32]
    Model-based multi-omics data integration to characterize multi-level ...
    Feb 7, 2022 · We propose INTEGRATE, a computational pipeline that integrates metabolomics and transcriptomics data, using constraint-based stoichiometric metabolic models as ...
  33. [33]
    Integration of proteomic data with genome‐scale metabolic models ...
    Sep 14, 2024 · This review explores methodologies for incorporating proteomics data into genome-scale models. Available methods are grouped into four distinct categories.2 Method Selection And... · 2.4 Fine-Grained Methods · 2.4. 1 Metabolism And...
  34. [34]
    Model Validation and Selection in Metabolic Flux Analysis ... - PMC
    13C-MFA flux estimates are typically validated based on the goodness-of-fit between measured labeling data and the corresponding values generated by the network ...
  35. [35]
    Metabolic networks in motion: 13 C‐based flux analysis - EMBO Press
    Methods for experimental determination of metabolic fluxes differ fundamentally from component concentration measurements; that is, intracellular reaction rates ...
  36. [36]
    Thermodynamic Constraints Improve Metabolic Networks - PMC - NIH
    In pursuit of establishing a realistic metabolic phenotypic space, the reversibility of reactions is thermodynamically constrained in modern metabolic networks.Missing: ΔG | Show results with:ΔG
  37. [37]
    A systematic comparison of the MetaCyc and KEGG pathway ...
    Mar 27, 2013 · The MetaCyc and KEGG projects have developed large metabolic pathway databases that are used for a variety of applications including genome ...
  38. [38]
    Introduction to BioCyc and Pathway Tools
    Metabolic Route Search: Search for reaction paths connecting specified metabolites in the metabolic network. Pathway Tools enables design of novel pathways ...Biocyc Benefits: Better... · Biocyc Database Collection · Biocyc.Org Bioinformatics...
  39. [39]
    MetaCyc database of metabolic pathways and enzymes
    Oct 5, 2019 · In addition to its role as a general reference on metabolism, MetaCyc is used by the PathoLogic component of the Pathway Tools software (3,4) ...
  40. [40]
    What is flux balance analysis? - PubMed - NIH
    Flux balance analysis is a mathematical approach for analyzing the flow of metabolites through a metabolic network. This primer covers the theoretical basis ...Missing: seminal | Show results with:seminal
  41. [41]
    Stoichiometric flux balance models quantitatively predict growth and ...
    The flux balance model specified by these parameters was found to quantitatively predict glucose and oxygen uptake rates as well as acetate secretion rates.Missing: original analysis
  42. [42]
    What is flux balance analysis? - PMC - NIH
    Flux balance analysis is a mathematical approach for analyzing the flow of metabolites through a metabolic network. This primer covers the theoretical basis ...Missing: seminal | Show results with:seminal
  43. [43]
    Metabolic flux balance analysis and the in silico analysis of ...
    Jul 27, 2000 · Alterations of the genotype. FBA and E. coli in silico were used to examine the systemic effects of in silico gene deletions. The genes involved ...
  44. [44]
    Structural kinetic modeling of metabolic networks - PNAS
    Here we propose a method that aims to give a quantitative account of the dynamical capabilities of a metabolic system, without requiring any explicit ...Abstract · Sign Up For Pnas Alerts · Glycolytic Pathway
  45. [45]
    A Review of Dynamic Modeling Approaches and Their Application in ...
    Metabolic network modeling can be based on the knowledge of enzyme mechanisms and experimental data to build a representation of a dynamic system, able to ...
  46. [46]
    Reconstructing Kinetic Models for Dynamical Studies of Metabolism ...
    Aug 30, 2022 · Kinetic models of metabolism relate metabolic fluxes, metabolite concentrations and enzyme levels through mechanistic relations, ...
  47. [47]
    A hybrid kinetic and constraint‐based model of leaf metabolism ...
    Oct 26, 2021 · Hybrid models composed of ODE and FBA models have been proposed as a way of addressing the limitations of both types of modelling, leading to a ...
  48. [48]
    Modeling the metabolic dynamics at the genome-scale by optimized ...
    The hybrid cybernetic model (HCM) approach is a dynamic modeling framework that integrates enzyme synthesis and activity regulation.
  49. [49]
    Parameter estimation of kinetic models from metabolic profiles - NIH
    In this work, an incremental and iterative parameter estimation method is proposed that combines and iterates between two estimation phases.2 Methods · 3 Results · 3.2 The Glycolytic Pathway...
  50. [50]
    A mathematical model of metabolic insulin signaling pathways
    We develop a mathematical model that explicitly represents many of the known signaling components mediating translocation of the insulin-responsive glucose ...
  51. [51]
    Mathematical Modeling of the Insulin Signal Transduction Pathway ...
    Our current mathematical model of the insulin signal transduction pathway comprises a set of ordinary differential equations (ODEs) describing all known events ...
  52. [52]
    From Saccharomyces cerevisiae to Ethanol: Unlocking the Power of ...
    In this review, we focus on key examples of metabolic and evolutionary engineering for improved first- and second-generation S. cerevisiae bioethanol ...Missing: seminal | Show results with:seminal
  53. [53]
    A Novel Semi-biosynthetic Route for Artemisinin Production Using ...
    Mar 9, 2009 · The initial overexpression of wild-type P450BM3 in E. coli engineered to produce amorphadiene demonstrated no detectable oxidation activity ...
  54. [54]
    Combining orthogonal CRISPR and CRISPRi systems for genome ...
    Jan 13, 2019 · The combination of orthogonal CRISPR/CRISPRi for metabolic engineering enhanced succinate production while inhibiting byproduct formation and ...2.2 Plasmid Construction · 2.5 Crispr-Mediated... · 3 Results
  55. [55]
    A new genome-scale metabolic model of Corynebacterium ...
    Jun 30, 2017 · Corynebacterium glutamicum is an important platform organism for industrial biotechnology to produce amino acids, organic acids, bioplastic ...
  56. [56]
    Metabolic engineering of Corynebacterium glutamicum aimed at ...
    In this review we focus on the state of the art of metabolic engineering of C. glutamicum for utilization of alternative carbon sources.
  57. [57]
    Mathematical Modeling of the Function of Warburg Effect in Tumor ...
    Jun 11, 2018 · A number of possible advantages of Warburg effect offered to cancer cells include enhanced biosynthetic activity, accelerated adenosine ...
  58. [58]
    Network modeling approaches for metabolic diseases and diabetes
    We present here a brief overview of network modeling methods applied to inborn errors of metabolism (IEM), systemic metabolic conditions (mainly diabetes),
  59. [59]
    Global reconstruction of the human metabolic network based on ...
    3-Hydroxy-3-methylglutaryl-CoA reductase (Entrez Gene ID 3156), a primary metabolic target of the antilipidemic class of statin drugs, is in this coupled ...
  60. [60]
    Pharmacokinetics in Pharmacometabolomics - NIH
    Nov 7, 2023 · Pharmacometabolomics is the most promising method for personalized medication. Within the domain of pharmacometabolomics, its synergy with ...
  61. [61]
    Drug Off-Target Effects Predicted Using Structural Analysis in the ...
    Sep 23, 2010 · As well, the model predicts no effect on renal reabsorption or secretion for a number of other predicted off-target metabolic proteins.
  62. [62]
    SARS-CoV-2 infection rewires host cell metabolism and is ... - Nature
    Mar 25, 2021 · We describe that SARS-CoV-2 infection rewires carbon entry into the TCA cycle, reducing oxidative glutamine metabolism and increasing pyruvate entry.